“We are grateful to all the people at the trial sites in the UnitedStates and in the PMS community who have enabled this GROUND BREAKING TRIAL to be completed as westrive to develop a potential first therapy for PMS. We look forward to releasing next month the firstresults of treatment with NNZ-2591 in children with PMS.”
If the bold lettering doesn’t scream “breakthrough designation” potential I don’t know what will. Remember, this is open label. My word this really gets my Johnson going.
- Forums
- ASX - By Stock
- Ann: Neuren completes Phelan-McDermid syndrome Phase 2 trial
“We are grateful to all the people at the trial sites in the...
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.34 |
Change
1.140(5.64%) |
Mkt cap ! $2.725B |
Open | High | Low | Value | Volume |
$20.30 | $21.65 | $20.11 | $14.34M | 673.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 633 | $21.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.34 | 2000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 250 | 21.300 |
1 | 1632 | 21.270 |
1 | 3047 | 21.240 |
1 | 190 | 21.230 |
3 | 2686 | 21.220 |
Price($) | Vol. | No. |
---|---|---|
21.400 | 1495 | 1 |
21.430 | 1054 | 2 |
21.440 | 80 | 1 |
21.560 | 1632 | 1 |
21.600 | 100 | 1 |
Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
Last
$21.37 |
  |
Change
1.140 ( 5.63 %) |
|||
Open | High | Low | Volume | ||
$20.26 | $21.64 | $20.19 | 136487 | ||
Last updated 15.59pm 15/05/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online